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Cereals are the basis of human nutrition; they are the
food source most intensively produced in the world, sur-
passing 2000 million tons annually. The production of
wheat, corn and rice makes up over the 70% of the total
cereal production and thus dominates world agriculture.
All 3 cereal crops can determine adverse reactions with
different mechanisms of immune-mediated hypersensi-
tivity and through various routes of exposure (digestive,
inhalation and contact). A paradigmatic example is that
of wheat , which that can cause a range of reactions
such as IgE-mediated food allergy, anaphylaxis and
asthma, exercise-induced systemic reactions and cell-
mediated reactions, such as celiac disease. The major
allergens of cereals are represented by alpha-amylase
inhibitors, some prolamins, such as gliadins in wheat
and zeins in maize, and Lipid Transfer Proteins. These
allergens are also differently implicated in the various
clinical forms. So that their positivity in many cases
actually can be considered diagnostic. The clinical diag-
nosis of allergy to cereals, because of their nutritional
importance, should always be verified by double-blind
placebo-controlled food challenged. Long term prog-
nosis is quite favourable and the therapy is based essen-
tially on their elimination, and on the treatment of
symptoms in the case of ingestion.
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